Key result
Elevated mitochondrial metabolites pyruvic and fumaric acid strongly correlate with higher circulating GDF-15 in heart failure.
Cross-Sectional (n=54)
No
Investigates GDF-15 associations with gut and mitochondrial metabolites in ageing populations, suggesting implications for oxidative stress markers.
Growth differentiation factor-15 (GDF-15) is an established marker of oxidative stress and a general stress-response mitokines. In this study, we aim to investigate the association of GDF-15 with the metabolic signature of gut and mitochondrial activity in HF and ageing population. A total of 25 HF (67.9 ± 10.0 years) and 29 age-matched healthy participants (HPs) (67.8 ± 11.1 years) were recruited and underwent detailed body composition assessment via dual X-ray absorptiometry; total fat mass and appendicular lean soft tissue index (ALSTI/body mass index (BMI)) were calculated. Utilizing semi-targeted Gas Chromatography–Mass Spectrometry on fasting plasma, a panel of gut microbial-derived (e.g., hippuric acid, indole derivatives, and sarcosine) and tricarboxylic acid cycle metabolites was identified. Results showed higher GDF-15 tertiles were associated with greater HF prevalence, fat mass, NT-proBNP, and TNF-α (p < 0.05). Gut-derived metabolites exhibited phenotype-specific patterns; 3-hydroxyindole predicted higher fat mass in HP; hippuric acid was inversely related in HF; and sarcosine correlated with GDF-15 only in HP. In HF, GDF-15 was strongly driven by pyruvic and fumaric acid, indicating disease-specific mitochondrial stress. In conclusion, these observed associations could be evaluated in future mechanistic studies as sensitive biomarkers of systemic oxidative stress markers, informing potential microbiome-targeted therapeutic avenues.
No takes yet. Share an insight, caveat, or question.
Prokopidis et al. (2026) conducted a cross-sectional in Chronic heart failure and healthy ageing (n=54). Circulating GDF-15, gut microbial metabolites, and mitochondrial TCA cycle metabolites vs. Age-matched healthy participants / lower GDF-15 tertiles was evaluated on Association of mitochondrial metabolites (pyruvic acid and fumaric acid) with circulating GDF-15 in heart failure (beta 0.70 (pyruvic acid); beta 0.73 (fumaric acid), p=<0.001). Higher circulating GDF-15 in heart failure was strongly predicted by mitochondrial metabolites pyruvic acid (β=0.70, p<0.001) and fumaric acid (β=0.73, p<0.001), alongside elevated NT-proBNP and TNF-α.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: